What the superinvestors bought and sold in 2026 Q1
2026 Q1
137 of 137 filedThe quarter at a glance
85 of 136 managers were net sellers. Setting price aside, they took $46.6B out, led by Energy (−$15.6B), while adding to Communication Services (+$7.3B). META was the most widely bought stock (25 bought, 9 sold); MSFT the most widely sold (34 sold, 17 bought).
Net buyers
42 of 136 managers
85 sold more than they bought · 9 about even
Net bought
−$46.6B
Price moves taken out; prices alone moved the book −$63.1B.
Positions opened
1,045
952 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
−4.4%
SPY −4.6%,
0.2 pts ahead.
Price only.
Most bought and sold
Ranked by how many managers bought minus how many sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 META Meta Platforms Inc. 25 bought · 9 sold +$1.4B
Bought by
- Robert Vinall - Rv Capital AG added 20.9% → 21.8%
- Brad Gerstner - Altimeter Capital Management added 18.3% → 19.6%
- Marc Stad - Dragoneer Investment Group opened 13.6% of book
- Nehal Chopra - Ratan Capital Management added 7.9% → 12.0%
- Ram Parameswaran - Octahedron Capital Management added 0.56% → 8.5%
- Chase Coleman - Tiger Global Management added 6.1% → 7.7%
- Lewis Sanders - Sanders Capital added 7.6% → 7.2%
- Triple Frond Partners added 6.7% → 7.0%
and 17 more
Sold by
- Valueact Capital - Valueact Holdings cut 9.8% → 9.2%
- David Rolfe - Wedgewood Partners cut 8.5% → 7.8%
- Philippe Laffont - Coatue Management cut 6.2% → 5.5%
- David Tepper - Appaloosa cut 5.7% → 4.2%
- Jensen Investment Management cut 3.8% → 3.8%
- Ruane, Cunniff & Goldfarb cut 2.5% → 1.9%
- Dan Sundheim - D1 Capital Partners closed was 2.3%
- Cathie Wood - Ark Investment Management cut 1.3% → 0.69%
and 1 more
-
2 URI Sunbelt Rentals Holdings, Inc. 13 bought · 1 sold +$6.3B
Bought by
- Abrams Bison - Abrams Bison Investments opened 35.4% of book
- Pat Dorsey - Dorsey Asset Management opened 11.4% of book
- Ruane, Cunniff & Goldfarb opened 5.9% of book
- Thomas Russo - Gardner Russo & Quinn opened 4.6% of book
- Ako Capital opened 4.1% of book
- Dodge & Cox opened 1.9% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 1.0% of book
- Thomas Gayner - Markel Group added 0.20% → 0.72%
and 5 more
Sold by
- Davidson Kempner Capital Management closed was 0.19%
-
3 INTC Intel Corp. 12 bought · 2 sold +$304M
Bought by
- Ram Parameswaran - Octahedron Capital Management added 2.2% → 5.4%
- Nehal Chopra - Ratan Capital Management opened 1.9% of book
- Ning Jin - Avantyr Capital Partners added 1.3% → 1.9%
- Lee Ainslie - Maverick Capital opened 1.5% of book
- Gavin Baker - Atreides Management added 0.22% → 0.58%
- Stanley Druckenmiller - Duquesne Family Office opened 0.54% of book
- Glenview Capital Management opened 0.44% of book
- James Silverman - Opaleye Management opened 0.41% of book
and 4 more
Sold by
- Murphy Pohlad - Murphy Pohlad Asset Management cut 2.0% → 2.0%
- Richard Pzena - Pzena Investment Management closed was <0.01%
-
4 TCOM Tripadvisor Inc. 8 bought · 0 sold +$201M
Bought by
- Starboard Value added 2.7% → 2.5%
- Mason Hawkins - Southeastern Asset Management added 1.8% → 2.4%
- Christopher Davis - Davis Selected Advisers added 1.6% → 1.5%
- Lewis Sanders - Sanders Capital added 0.82% → 0.63%
- George Soros - Soros Fund Management added 0.09% → 0.53%
- David Einhorn - DME Capital Management opened 0.52% of book
- Lee Ainslie - Maverick Capital opened <0.01% of book
- Dodge & Cox added <0.01% → <0.01%
Sold by
No manager sold.
-
5 ASML Asml Hldg NV 12 bought · 5 sold +$914M
Bought by
- Triple Frond Partners added 11.9% → 16.3%
- Ning Jin - Avantyr Capital Partners added 4.7% → 8.5%
- Stephen Mandel - Lone Pine Capital added 4.8% → 6.9%
- Dev Kantesaria - Valley Forge Capital Management added 3.1% → 6.7%
- Philippe Laffont - Coatue Management opened 2.3% of book
- Dan Loeb - Third Point opened 0.76% of book
- Wallace Weitz - Weitz Investment Management opened 0.51% of book
- Ben Hoskin - Value Aligned Research Advisors added <0.01% → 0.45%
and 4 more
Sold by
- Pat Dorsey - Dorsey Asset Management cut 17.9% → 14.8%
- Hillman Capital Management closed was 3.7%
- David Tepper - Appaloosa cut 0.97% → 1.1%
- Davidson Kempner Capital Management cut 0.42% → 0.36%
- Duan Yongping - H&H International Investment closed was 0.06%
-
6 MU Micron Technology Inc. 9 bought · 2 sold +$146M
Bought by
- David Tepper - Appaloosa added 6.2% → 9.5%
- Ram Parameswaran - Octahedron Capital Management opened 3.8% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.23% of book
- Davidson Kempner Capital Management opened 0.20% of book
- Philippe Laffont - Coatue Management opened 0.19% of book
- Situational Awareness opened 0.04% of book
- George Soros - Soros Fund Management opened 0.01% of book
- Mairs & Power opened <0.01% of book
and 1 more
Sold by
- Spencer Waxman - Shannon River Fund Management closed was 0.91%
- Ron Baron - Bamco Inc. (Baron Capital) cut <0.01% → <0.01%
-
7 FISV Fiserv, Inc. 9 bought · 3 sold +$631M
Bought by
- Jana Partners Management added 7.8% → 15.4%
- Hillman Capital Management added 1.6% → 3.1%
- Samantha Mclemore - Patient Capital Management added 0.67% → 2.0%
- Bill Nygren / Oakmark - Harris Associates L P added 1.3% → 1.5%
- Mairs & Power added 1.1% → 1.2%
- Murphy Pohlad - Murphy Pohlad Asset Management added 0.64% → 0.70%
- First Eagle Investment Management opened 0.55% of book
- John Rogers - Ariel Investments added 0.23% → 0.27%
and 1 more
Sold by
- Seth Klarman - Baupost Group closed was 2.8%
- Vulcan Value Partners cut 1.8% → 1.6%
- Lewis Sanders - Sanders Capital closed was 0.18%
-
8 CRWV Coreweave Inc. 7 bought · 1 sold +$540M
Bought by
- Brad Gerstner - Altimeter Capital Management added 3.5% → 6.1%
- Situational Awareness added 7.9% → 4.1%
- Ben Hoskin - Value Aligned Research Advisors added 4.3% → 3.1%
- Cathie Wood - Ark Investment Management added 0.91% → 1.5%
- Gavin Baker - Atreides Management added 0.53% → 1.3%
- George Soros - Soros Fund Management opened 0.37% of book
- Andreas Halvorsen - Viking Global Investors opened 0.30% of book
Sold by
- Duan Yongping - H&H International Investment closed was 0.12%
-
9 WAT Waters Corp. 7 bought · 2 sold +$926M
Bought by
- Ako Capital added 4.4% → 4.8%
- First Pacific Advisors opened 1.1% of book
- Andreas Halvorsen - Viking Global Investors opened 1.0% of book
- Robert Olstein - Olstein Capital Management opened 0.65% of book
- First Eagle Investment Management opened 0.62% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 0.11% of book
- Mairs & Power opened <0.01% of book
Sold by
- Terry Smith - Fundsmith cut 7.9% → 7.5%
- David Witzke - Avidity Partners Management closed was 0.89%
-
10 LIN Linde PLC 8 bought · 3 sold +$780M
Bought by
- John Armitage - Egerton Capital (UK) opened 5.9% of book
- Ben Jacobs - Anomaly Capital Management opened 3.1% of book
- Ning Jin - Avantyr Capital Partners opened 2.5% of book
- Lee Ainslie - Maverick Capital opened 2.4% of book
- George Soros - Soros Fund Management opened 1.4% of book
- Ako Capital added 0.09% → 1.3%
- Stanley Druckenmiller - Duquesne Family Office opened 0.60% of book
- Kentucky Trust Co. - Kentucky Trust added 0.04% → 0.05%
Sold by
- Estuary Capital Management closed was 4.5%
- Dan Sundheim - D1 Capital Partners closed was 1.9%
- Davidson Kempner Capital Management cut 0.44% → 0.37%
Not counted as buying: 191 IPOs, spin-offs and new listings.
Most sold
-
1 MSFT Microsoft Corp. 17 bought · 34 sold −$11.3B
Sold by
- Robert Karr - Joho Capital cut 37.1% → 30.6%
- Altarock Partners cut 19.7% → 16.8%
- Chris Hohn - Tci Fund Management cut 15.1% → 2.2%
- Eric Mandelblatt - Soroban Capital Partners cut 14.0% → 2.6%
- Gates Foundation Trust closed was 10.5%
- Vulcan Value Partners cut 10.1% → 10.9%
- Jensen Investment Management cut 10.1% → 8.5%
- Brad Gerstner - Altimeter Capital Management cut 9.3% → 7.7%
and 26 more
Bought by
- Grant Wonders - Voyager Global Management added 14.5% → 16.7%
- David Katz - Matrix Asset Advisors added 6.2% → 5.8%
- Farallon Capital Management added 5.1% → 4.9%
- Wallace Weitz - Weitz Investment Management added 4.2% → 4.4%
- Torray Investment Partners added 2.4% → 4.2%
- Robert Vinall - Rv Capital AG added 1.3% → 2.5%
- Dodge & Cox added 1.9% → 2.4%
- Arnold Van Den Berg - Van Den Berg Management I added 1.9% → 2.3%
and 9 more
-
2 GOOGL / GOOG Alphabet 18 bought · 35 sold +$9.5B
Sold by
- Lindsell Train cut 16.6% → 15.6%
- Ruane, Cunniff & Goldfarb cut 16.2% → 14.6%
- First Pacific Advisors cut 13.5% → 12.1%
- Thomas Russo - Gardner Russo & Quinn cut 13.4% → 11.4%
- Lewis Sanders - Sanders Capital cut 11.5% → 9.8%
- David Abrams - Abrams Capital Management cut 10.6% → 11.6%
- Francois Rochon - Giverny Capital cut 10.5% → 10.2%
- David Rolfe - Wedgewood Partners cut 9.6% → 9.2%
and 27 more
Bought by
- Andrew Steginsky - Steginsky Capital added 36.2% → 33.1%
- Mala Gaonkar - Surgocap Partners added 10.9% → 14.3%
- John Armitage - Egerton Capital (UK) added 3.7% → 11.0%
- Alex Sacerdote - Whale Rock Capital Management added 8.4% → 9.9%
- Chris Hohn - Tci Fund Management added 4.4% → 7.2%
- Seth Klarman - Baupost Group added 6.5% → 6.6%
- Warren Buffett - Berkshire Hathaway added 2.0% → 6.3%
- Duan Yongping - H&H International Investment added 3.3% → 5.3%
and 10 more
-
3 TSM Taiwan Semiconductor Manufac 12 bought · 23 sold −$2.7B
Sold by
- Glen Kacher - Light Street Capital Management cut 12.6% → 14.4%
- Lewis Sanders - Sanders Capital cut 11.2% → 11.3%
- Grant Wonders - Voyager Global Management cut 10.9% → 13.2%
- David Rolfe - Wedgewood Partners cut 10.5% → 9.0%
- Stephen Mandel - Lone Pine Capital cut 6.8% → 3.7%
- Ruane, Cunniff & Goldfarb cut 6.7% → 6.8%
- Ram Parameswaran - Octahedron Capital Management cut 6.7% → 5.7%
- Lee Ainslie - Maverick Capital cut 5.4% → 4.8%
and 15 more
Bought by
- Philippe Laffont - Coatue Management added 6.6% → 10.8%
- Chase Coleman - Tiger Global Management added 3.8% → 8.2%
- Brad Gerstner - Altimeter Capital Management added 5.6% → 8.1%
- David Tepper - Appaloosa added 5.0% → 7.6%
- Alex Sacerdote - Whale Rock Capital Management added 2.3% → 3.6%
- George Soros - Soros Fund Management added 1.2% → 1.9%
- Dan Sundheim - D1 Capital Partners opened 0.99% of book
- Wallace Weitz - Weitz Investment Management opened 0.47% of book
and 4 more
-
4 BAC Bank America Corp. 2 bought · 11 sold −$943M
Sold by
- Li Lu - Himalaya Capital Management cut 16.1% → 4.6%
- Ning Jin - Avantyr Capital Partners closed was 5.3%
- Arnold Van Den Berg - Van Den Berg Management I cut 0.74% → 0.58%
- Andreas Halvorsen - Viking Global Investors closed was 0.66%
- Dan Sundheim - D1 Capital Partners closed was 0.64%
- Murphy Pohlad - Murphy Pohlad Asset Management cut 0.64% → 0.41%
- Steven Check - Check Capital Management cut 0.13% → 0.02%
- Kahn Brothers Group cut 0.10% → 0.08%
and 3 more
Bought by
- Harry Burn - Sound Shore Management added 2.8% → 3.4%
- Ron Baron - Bamco Inc. (Baron Capital) opened <0.01% of book
-
5 GS The Goldman Sachs Group, Inc. 0 bought · 8 sold −$321M
Sold by
- David Katz - Matrix Asset Advisors cut 2.2% → 2.0%
- Dodge & Cox cut 0.81% → 0.64%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.54%
- Robert Olstein - Olstein Capital Management cut 0.27% → 0.22%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.04% → 0.03%
- Richard Pzena - Pzena Investment Management closed was 0.03%
- John Rogers - Ariel Investments closed was 0.03%
- Murray Stahl - Horizon Kinetics Asset Management cut 0.01% → <0.01%
Bought by
No manager bought.
-
6 WFC Wells Fargo & Co. 0 bought · 7 sold −$398M
Sold by
- Tweedy, Browne Co. cut 4.2% → 3.3%
- Richard Pzena - Pzena Investment Management cut 2.8% → 2.3%
- Mairs & Power cut 1.6% → 1.1%
- Bill Nygren / Oakmark - Harris Associates L P cut 1.5% → 1.2%
- First Pacific Advisors cut 1.4% → 0.97%
- Steven Check - Check Capital Management cut 0.01% → 0.01%
- Thomas Russo - Gardner Russo & Quinn cut <0.01% → <0.01%
Bought by
No manager bought.
-
7 BN Brookfield Corp. 1 bought · 8 sold −$383M
Sold by
- Chuck Akre - Akre Capital Management cut 13.5% → 11.2%
- Stephen Mandel - Lone Pine Capital cut 5.4% → 3.6%
- Third Avenue Management cut 4.6% → 3.2%
- Dan Loeb - Third Point closed was 3.9%
- Arnold Van Den Berg - Van Den Berg Management I cut 3.1% → 2.2%
- Eric Mandelblatt - Soroban Capital Partners closed was 1.8%
- Ron Baron - Bamco Inc. (Baron Capital) cut 0.45% → 0.35%
- Kahn Brothers Group closed was 0.04%
Bought by
- Dodge & Cox added 1.0% → 1.3%
-
8 FDX Fedex Corp. 2 bought · 8 sold −$1.4B
Sold by
- Mason Hawkins - Southeastern Asset Management cut 4.6% → 4.3%
- Tweedy, Browne Co. cut 2.6% → 2.1%
- Dodge & Cox cut 2.4% → 2.0%
- Robert Olstein - Olstein Capital Management cut 1.5% → 1.0%
- David Katz - Matrix Asset Advisors cut 1.4% → 1.4%
- Ryan Packard - Hiddenite Capital Partners closed was 1.2%
- Lee Ainslie - Maverick Capital cut 0.08% → <0.01%
- Steven Check - Check Capital Management cut 0.02% → 0.01%
Bought by
- Andreas Halvorsen - Viking Global Investors opened 1.9% of book
- John Rogers - Ariel Investments added 0.22% → 0.39%
-
9 HCA Hca Healthcare Inc. 1 bought · 7 sold −$977M
Sold by
- Abrams Bison - Abrams Bison Investments closed was 5.7%
- Lewis Sanders - Sanders Capital cut 5.6% → 5.1%
- Lyrical Asset Management cut 4.4% → 4.8%
- First Eagle Investment Management cut 3.0% → 2.0%
- Richard Pzena - Pzena Investment Management cut 0.14% → 0.14%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.11% → 0.10%
- Glenn Greenberg - Brave Warrior Advisors cut 0.04% → 0.02%
Bought by
- Andreas Halvorsen - Viking Global Investors added 1.2% → 1.4%
-
10 GEV Ge Vernova Inc. 0 bought · 6 sold −$957M
Sold by
- Philippe Laffont - Coatue Management cut 5.5% → 7.7%
- Ben Hoskin - Value Aligned Research Advisors cut 1.8% → 0.19%
- Ben Jacobs - Anomaly Capital Management closed was 1.5%
- Dodge & Cox cut 0.05% → 0.06%
- Steven Check - Check Capital Management cut 0.02% → 0.02%
- Mairs & Power cut <0.01% → <0.01%
Bought by
No manager bought.
Not counted as selling: 143 mergers and delistings.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
URI Sunbelt Rentals Holdings, Inc. 11 managers avg 6.0% of book · Abrams Bison - Abrams Bison Investments, Pat Dorsey - Dorsey Asset Management and 9 more
Opened by
- Abrams Bison - Abrams Bison Investments opened 35.4% of book
- Pat Dorsey - Dorsey Asset Management opened 11.4% of book
- Ruane, Cunniff & Goldfarb opened 5.9% of book
- Thomas Russo - Gardner Russo & Quinn opened 4.6% of book
- Ako Capital opened 4.1% of book
- Dodge & Cox opened 1.9% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 1.0% of book
- Francois Rochon - Giverny Capital opened 0.65% of book
and 3 more
-
META Meta Platforms Inc. 8 managers avg 4.1% of book · Marc Stad - Dragoneer Investment Group, Ning Jin - Avantyr Capital Partners and 6 more
Opened by
- Marc Stad - Dragoneer Investment Group opened 13.6% of book
- Ning Jin - Avantyr Capital Partners opened 5.4% of book
- Grant Wonders - Voyager Global Management opened 4.4% of book
- Estuary Capital Management opened 3.4% of book
- Dan Loeb - Third Point opened 2.5% of book
- Polen Capital Management opened 1.9% of book
- Andreas Halvorsen - Viking Global Investors opened 1.7% of book
- George Soros - Soros Fund Management opened 0.22% of book
-
INTC Intel Corp. 8 managers avg 0.68% of book · Nehal Chopra - Ratan Capital Management, Lee Ainslie - Maverick Capital and 6 more
Opened by
- Nehal Chopra - Ratan Capital Management opened 1.9% of book
- Lee Ainslie - Maverick Capital opened 1.5% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.54% of book
- Glenview Capital Management opened 0.44% of book
- James Silverman - Opaleye Management opened 0.41% of book
- Chase Coleman - Tiger Global Management opened 0.32% of book
- David Witzke - Avidity Partners Management opened 0.23% of book
- Ben Hoskin - Value Aligned Research Advisors opened 0.11% of book
-
MU Micron Technology Inc. 8 managers avg 0.56% of book · Ram Parameswaran - Octahedron Capital Management, Stanley Druckenmiller - Duquesne Family Office and 6 more
Opened by
- Ram Parameswaran - Octahedron Capital Management opened 3.8% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.23% of book
- Davidson Kempner Capital Management opened 0.20% of book
- Philippe Laffont - Coatue Management opened 0.19% of book
- Situational Awareness opened 0.04% of book
- George Soros - Soros Fund Management opened 0.01% of book
- Mairs & Power opened <0.01% of book
- Kentucky Trust Co. - Kentucky Trust opened <0.01% of book
-
V Visa Inc. 7 managers avg 3.5% of book · Ning Jin - Avantyr Capital Partners, Ben Jacobs - Anomaly Capital Management and 5 more
Opened by
- Ning Jin - Avantyr Capital Partners opened 8.6% of book
- Ben Jacobs - Anomaly Capital Management opened 4.5% of book
- Seth Klarman - Baupost Group opened 4.1% of book
- Senator Investment Group opened 2.9% of book
- Mala Gaonkar - Surgocap Partners opened 2.9% of book
- Philippe Laffont - Coatue Management opened 0.75% of book
- Gavin Baker - Atreides Management opened 0.43% of book
-
LIN Linde PLC 6 managers avg 2.7% of book · John Armitage - Egerton Capital (UK), Ben Jacobs - Anomaly Capital Management and 4 more
Opened by
- John Armitage - Egerton Capital (UK) opened 5.9% of book
- Ben Jacobs - Anomaly Capital Management opened 3.1% of book
- Ning Jin - Avantyr Capital Partners opened 2.5% of book
- Lee Ainslie - Maverick Capital opened 2.4% of book
- George Soros - Soros Fund Management opened 1.4% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.60% of book
-
GLW Corning Inc. 6 managers avg 1.8% of book · Stephen Mandel - Lone Pine Capital, Mala Gaonkar - Surgocap Partners and 4 more
Opened by
- Stephen Mandel - Lone Pine Capital opened 4.0% of book
- Mala Gaonkar - Surgocap Partners opened 3.9% of book
- Harry Burn - Sound Shore Management opened 2.1% of book
- Lee Ainslie - Maverick Capital opened 0.59% of book
- Murphy Pohlad - Murphy Pohlad Asset Management opened 0.11% of book
- Situational Awareness opened <0.01% of book
-
VST Vistra Corp. 6 managers avg 1.7% of book · Ryan Packard - Hiddenite Capital Partners, King Street Capital Management and 4 more
Opened by
- Ryan Packard - Hiddenite Capital Partners opened 3.2% of book
- King Street Capital Management opened 2.7% of book
- Harry Burn - Sound Shore Management opened 2.4% of book
- Gavin Baker - Atreides Management opened 1.6% of book
- George Soros - Soros Fund Management opened 0.40% of book
- Kentucky Trust Co. - Kentucky Trust opened <0.01% of book
-
LITE Lumentum Hldgs Inc. 6 managers avg 1.5% of book · Estuary Capital Management, Nehal Chopra - Ratan Capital Management and 4 more
Opened by
- Estuary Capital Management opened 6.2% of book
- Nehal Chopra - Ratan Capital Management opened 1.8% of book
- Chase Coleman - Tiger Global Management opened 0.42% of book
- Glen Kacher - Light Street Capital Management opened 0.38% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.14% of book
- Lee Ainslie - Maverick Capital opened 0.02% of book
-
WAT Waters Corp. 6 managers avg 0.59% of book · First Pacific Advisors, Andreas Halvorsen - Viking Global Investors and 4 more
Opened by
- First Pacific Advisors opened 1.1% of book
- Andreas Halvorsen - Viking Global Investors opened 1.0% of book
- Robert Olstein - Olstein Capital Management opened 0.65% of book
- First Eagle Investment Management opened 0.62% of book
- Bill Nygren / Oakmark - Harris Associates L P opened 0.11% of book
- Mairs & Power opened <0.01% of book
Closed out by the most managers
-
MSFT Microsoft Corp. 7 managers was avg 6.1% of book · Gates Foundation Trust, John Armitage - Egerton Capital (UK) and 5 more
Closed by
- Gates Foundation Trust closed was 10.5%
- John Armitage - Egerton Capital (UK) closed was 9.2%
- Ning Jin - Avantyr Capital Partners closed was 6.3%
- Dan Loeb - Third Point closed was 6.1%
- Ben Jacobs - Anomaly Capital Management closed was 5.2%
- Stephen Mandel - Lone Pine Capital closed was 4.4%
- Gavin Baker - Atreides Management closed was 1.1%
-
UNH Unitedhealth Group, Inc. 7 managers was avg 0.64% of book · Torray Investment Partners, Andreas Halvorsen - Viking Global Investors and 5 more
Closed by
- Torray Investment Partners closed was 2.8%
- Andreas Halvorsen - Viking Global Investors closed was 1.0%
- Warren Buffett - Berkshire Hathaway closed was 0.61%
- David Katz - Matrix Asset Advisors closed was 0.02%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
- Polen Capital Management closed was <0.01%
- Bill Nygren / Oakmark - Harris Associates L P closed was <0.01%
-
MELI Mercadolibre Inc. 6 managers was avg 3.0% of book · Marc Stad - Dragoneer Investment Group, Ram Parameswaran - Octahedron Capital Management and 4 more
Closed by
- Marc Stad - Dragoneer Investment Group closed was 7.0%
- Ram Parameswaran - Octahedron Capital Management closed was 5.8%
- Alex Sacerdote - Whale Rock Capital Management closed was 2.5%
- Brad Gerstner - Altimeter Capital Management closed was 2.1%
- Davidson Kempner Capital Management closed was 0.24%
- Gavin Baker - Atreides Management closed was 0.11%
-
U Unity Software Inc. 6 managers was avg 1.8% of book · Spencer Waxman - Shannon River Fund Management, Ben Jacobs - Anomaly Capital Management and 4 more
Closed by
- Spencer Waxman - Shannon River Fund Management closed was 7.4%
- Ben Jacobs - Anomaly Capital Management closed was 1.8%
- Nehal Chopra - Ratan Capital Management closed was 1.5%
- Cathie Wood - Ark Investment Management closed was 0.29%
- George Soros - Soros Fund Management closed was <0.01%
- Polen Capital Management closed was <0.01%
-
COF Capital One Finl Corp. 5 managers was avg 2.7% of book · John Armitage - Egerton Capital (UK), Senator Investment Group and 3 more
Closed by
- John Armitage - Egerton Capital (UK) closed was 5.5%
- Senator Investment Group closed was 4.6%
- Harry Burn - Sound Shore Management closed was 2.8%
- John Rogers - Ariel Investments closed was 0.42%
- Francois Rochon - Giverny Capital closed was 0.07%
-
UAL United Airls Hldgs Inc. 5 managers was avg 2.0% of book · Eric Khrom - Khrom Capital Management, Ben Jacobs - Anomaly Capital Management and 3 more
Closed by
- Eric Khrom - Khrom Capital Management closed was 4.9%
- Ben Jacobs - Anomaly Capital Management closed was 4.1%
- David Tepper - Appaloosa closed was 0.75%
- Davidson Kempner Capital Management closed was 0.11%
- Lee Ainslie - Maverick Capital closed was 0.03%
-
SE Sea Ltd 5 managers was avg 1.9% of book · Ben Jacobs - Anomaly Capital Management, Ram Parameswaran - Octahedron Capital Management and 3 more
Closed by
- Ben Jacobs - Anomaly Capital Management closed was 3.8%
- Ram Parameswaran - Octahedron Capital Management closed was 3.6%
- Ning Jin - Avantyr Capital Partners closed was 1.9%
- Gavin Baker - Atreides Management closed was 0.43%
- First Eagle Investment Management closed was <0.01%
-
CEG Constellation Energy Corp. 5 managers was avg 1.4% of book · Glen Kacher - Light Street Capital Management, Dan Loeb - Third Point and 3 more
Closed by
- Glen Kacher - Light Street Capital Management closed was 3.4%
- Dan Loeb - Third Point closed was 2.3%
- Ben Hoskin - Value Aligned Research Advisors closed was 1.1%
- Glenview Capital Management closed was 0.22%
- Polen Capital Management closed was <0.01%
-
FLUT Flutter Entmt PLC 5 managers was avg 0.82% of book · Chase Coleman - Tiger Global Management, Stanley Druckenmiller - Duquesne Family Office and 3 more
Closed by
- Chase Coleman - Tiger Global Management closed was 2.9%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.55%
- Lee Ainslie - Maverick Capital closed was 0.43%
- George Soros - Soros Fund Management closed was 0.23%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
-
Rh Rh 5 managers was avg 0.77% of book · King Street Capital Management, Ben Jacobs - Anomaly Capital Management and 3 more
Closed by
- King Street Capital Management closed was 2.2%
- Ben Jacobs - Anomaly Capital Management closed was 0.93%
- Glenview Capital Management closed was 0.41%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.35%
- Lee Ainslie - Maverick Capital closed was 0.02%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Communication Services 9.0% weight · no change +$7.3B 32 bought · 46 sold
- Real Estate 3.0% weight · −0.3 pts +$446M 16 bought · 24 sold
- Consumer Discretionary 15.6% weight · no change −$1.5B 44 bought · 50 sold
- Materials 3.6% weight · −0.2 pts −$2.2B 14 bought · 31 sold
- Utilities 1.5% weight · +0.1 pts −$2.5B 13 bought · 17 sold
- Financials 16.7% weight · −0.6 pts −$2.7B 43 bought · 50 sold
- Consumer Staples 3.1% weight · +0.2 pts −$2.8B 19 bought · 23 sold
- Health Care 13.0% weight · +0.3 pts −$3.3B 30 bought · 45 sold
- Industrials 10.7% weight · +0.3 pts −$4.6B 27 bought · 56 sold
- Information Technology 19.2% weight · −0.4 pts −$13.5B 39 bought · 58 sold
- Energy 4.7% weight · +0.6 pts −$15.6B 17 bought · 35 sold
Energy gained weight (+0.6 pts) even though managers sold $15.6B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): −$336M.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Abrams Bison - Abrams Bison Investments opened URI · Sunbelt Rentals Holdings, Inc. 35.4% of book
- Josh Kushner - Thrive Capital Management opened SHOP · Shopify Inc. 30.9% of book
- Rule One Partners opened CRM · Salesforce Inc. 16.1% of book
- Eric Khrom - Khrom Capital Management opened COF · Capital One Finl Corp. 13.7% of book
- Marc Stad - Dragoneer Investment Group opened META · Meta Platforms Inc. 13.6% of book
- Pat Dorsey - Dorsey Asset Management opened URI · Sunbelt Rentals Holdings, Inc. 11.4% of book
Most active managers
- Ning Jin - Avantyr Capital Partners 10 opened · 14 closed · +$476M net 104% of book traded
- Estuary Capital Management 10 opened · 10 closed · +$58M net 99% of book traded
- Ben Jacobs - Anomaly Capital Management 10 opened · 23 closed · −$1.1B net 85% of book traded
- Eric Khrom - Khrom Capital Management 5 opened · 4 closed · +$184M net 81% of book traded
- Ram Parameswaran - Octahedron Capital Management 8 opened · 6 closed · +$7M net 81% of book traded
- Dan Loeb - Third Point 10 opened · 19 closed · −$4.9B net 75% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, each manager counting once. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 75 managers −1
- 2 AMZN Amazon Com Inc. 61 managers −1
- 3 MSFT Microsoft Corp. 60 managers −5
- 4 META Meta Platforms Inc. 49 managers +6
- 5 NVDA Nvidia Corporation 45 managers +4
- 6 TSM Taiwan Semiconductor Manufac 45 managers +2
- 7 V Visa Inc. 40 managers +4
- 8 BRK.B / BRK.A Berkshire Hathaway 36 managers +1
- 9 AAPL Apple Inc. 31 managers +1
- 10 DIS Disney Walt Co. 31 managers −1
Largest
- 1 GOOGL / GOOG Alphabet 3.4% held by 75
- 2 AMZN Amazon Com Inc. 2.8% held by 61
- 3 BRK.B / BRK.A Berkshire Hathaway 2.4% held by 36
- 4 MSFT Microsoft Corp. 1.8% held by 60
- 5 META Meta Platforms Inc. 1.6% held by 49
- 6 NVDA Nvidia Corporation 1.6% held by 45
- 7 CVNA Carvana Co. 1.5% held by 17
- 8 TSM Taiwan Semiconductor Manufac 1.3% held by 45
- 9 V Visa Inc. 1.1% held by 40
- 10 MA Mastercard Incorporated 0.83% held by 30
Highest conviction
- 1 DNTH Dianthus Therapeutics Inc. avg 14.1% held by 3
- 2 SGRY Surgery Partners Inc. avg 12.8% held by 3
- 3 CVNA Carvana Co. avg 12.3% held by 17
- 4 GIL Gildan Activewear Inc. avg 11.5% held by 3
- 5 BRK.B / BRK.A Berkshire Hathaway avg 9.2% held by 36
- 6 SNX Td Synnex Corporation avg 9.2% held by 5
- 7 UTHR United Therapeutics Corp. avg 8.4% held by 3
- 8 RIG Transocean Ltd avg 8.2% held by 4
- 9 IBKR Interactive Brokers Group In avg 7.9% held by 7
- 10 NVAX Novavax Inc. avg 7.8% held by 3
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+44.2%
SPY
+37.2%
Difference
+6.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+7.5% Combined book
+5.4% SPY
That quarter: book +7.5%, SPY +5.4%
2024 Q4, since 2024 Q2
+10.2% Combined book
+7.7% SPY
That quarter: book +2.6%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −3.8%, SPY −4.6%
2025 Q2, since 2024 Q2
+18.3% Combined book
+13.5% SPY
That quarter: book +11.6%, SPY +10.5%
2025 Q3, since 2024 Q2
+29.0% Combined book
+22.4% SPY
That quarter: book +9.1%, SPY +7.8%
2025 Q4, since 2024 Q2
+31.8% Combined book
+25.3% SPY
That quarter: book +2.1%, SPY +2.4%
2026 Q1, since 2024 Q2
+25.9% Combined book
+19.5% SPY
That quarter: book −4.4%, SPY −4.6%
2026 Q2, since 2024 Q2
+44.2% Combined book
+37.2% SPY
That quarter: book +14.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −0.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.2 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | −0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | +1.2 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | +1.1 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +0.7 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | +0.4 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +2.1 pts | 133 |
All 2,540 names
Download CSVShowing 300 of 423 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group, Inc. | Health Care | 27 −4 | 0.24% | −$1.5B | 11 / 15 | 3 / 7 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 19 −3 | 0.25% | +$800M | 7 / 8 | 1 / 4 |
| JNJ | Johnson & Johnson | Health Care | 19 +2 | 0.13% | −$24M | 4 / 6 | 2 / 0 |
| DHR | Danaher Corp. Del | Health Care | 17 −2 | 0.30% | +$511M | 4 / 8 | 1 / 3 |
| CVS | Cvs Health Corp. | Health Care | 16 +2 | 0.32% | −$1.1B | 5 / 7 | 3 / 1 |
| ELV | Elevance Health Inc. Formerly | Health Care | 15 +1 | 0.26% | −$21M | 2 / 3 | 1 / 0 |
| MRK | Merck & Co. Inc. | Health Care | 15 +3 | 0.08% | −$208M | 3 / 5 | 3 / 0 |
| PFE | Pfizer Inc. | Health Care | 13 +1 | 0.13% | +$88M | 5 / 5 | 2 / 1 |
| ABT | Abbott Laboratories | Health Care | 13 +2 | 0.05% | −$261M | 4 / 5 | 4 / 2 |
| ICLR | Icon PLC | Health Care | 12 +2 | 0.21% | +$1B | 6 / 5 | 4 / 2 |
| MDT | Medtronic PLC | Health Care | 12 +1 | 0.11% | +$83M | 1 / 2 | 1 / 0 |
| LLY | Eli Lilly & Co. | Health Care | 12 +1 | 0.10% | −$330M | 2 / 3 | 1 / 0 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 12 +2 | 0.10% | +$125M | 7 / 3 | 3 / 1 |
| ABBV | Abbvie Inc. | Health Care | 12 | 0.04% | −$7M | 0 / 2 | 0 / 0 |
| CI | The Cigna Group | Health Care | 11 −1 | 0.15% | +$1.2B | 4 / 3 | 1 / 2 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 11 −2 | 0.08% | −$192M | 2 / 3 | 0 / 2 |
| MDLN | Medline Inc. | Health Care | 10 +1 | 0.18% | +$638M | 6 / 5 | 4 / 3 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 10 −1 | 0.07% | −$205M | 2 / 4 | 0 / 1 |
| NTRA | Natera Inc. | Health Care | 9 | 0.21% | −$11M | 3 / 5 | 0 / 0 |
| WAT | Waters Corp. | Health Care | 9 +5 | 0.12% | +$926M | 7 / 2 | 6 / 1 |
| BAX | Baxter Intl Inc. | Health Care | 9 | 0.11% | −$55M | 5 / 3 | 1 / 1 |
| BDX | Becton Dickinson & Co. | Health Care | 9 +1 | 0.09% | −$92M | 1 / 3 | 1 / 0 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 9 −1 | 0.09% | +$90M | 5 / 3 | 0 / 1 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 8 | 0.11% | −$425M | 2 / 5 | 0 / 0 |
| HCA | Hca Healthcare Inc. | Health Care | 8 −1 | 0.10% | −$977M | 1 / 7 | 0 / 1 |
| GSK | Gsk PLC | Health Care | 8 | 0.07% | −$547M | 1 / 4 | 0 / 0 |
| ISRG | Intuitive Surgical Inc. | Health Care | 8 | 0.07% | −$24M | 5 / 2 | 1 / 1 |
| BSX | Boston Scientific Corp. | Health Care | 8 −3 | 0.05% | −$800M | 2 / 7 | 1 / 4 |
| NVO | Novo Nordisk A/S | Health Care | 8 +1 | 0.02% | +$819M | 4 / 2 | 3 / 2 |
| AZN | Astrazeneca PLC IPO or spin-off | Health Care | 7 +7 | 0.14% | +$2.9B | 7 / 0 | 7 / 0 |
| SYK | Stryker Corporation | Health Care | 7 +2 | 0.10% | −$130M | 2 / 2 | 2 / 0 |
| IDXX | Idexx Labs Inc. | Health Care | 7 | 0.10% | −$472M | 1 / 3 | 0 / 0 |
| BIIB | Biogen Inc. | Health Care | 7 | 0.09% | −$129M | 1 / 4 | 0 / 0 |
| TECH | Bio-Techne Corp. | Health Care | 7 | 0.09% | +$206M | 3 / 3 | 0 / 0 |
| AVTR | Avantor, Inc. | Health Care | 7 +2 | 0.06% | +$110M | 5 / 0 | 2 / 0 |
| HUM | Humana, Inc. | Health Care | 7 +2 | 0.06% | +$335M | 5 / 1 | 3 / 1 |
| AMGN | Amgen Inc. | Health Care | 7 −1 | 0.05% | −$21M | 0 / 3 | 0 / 1 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 | 0.02% | +$305K | 0 / 3 | 0 / 0 |
| NVS | Novartis AG | Health Care | 7 −1 | 0.02% | −$313M | 1 / 4 | 0 / 1 |
| CAH | Cardinal Health Inc. | Health Care | 7 | 0.01% | −$52M | 1 / 4 | 1 / 1 |
| ILMN | Illumina Inc. | Health Care | 6 | 0.20% | −$63M | 0 / 3 | 0 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 6 +3 | 0.17% | −$64M | 3 / 2 | 3 / 0 |
| ACHC | Acadia Healthcare Company In | Health Care | 6 +1 | 0.14% | +$6M | 4 / 2 | 2 / 1 |
| SOLV | Solventum Corporation | Health Care | 6 | 0.12% | −$8M | 0 / 1 | 0 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 6 −1 | 0.10% | −$153M | 0 / 3 | 0 / 1 |
| THC | Tenet Healthcare Corp. | Health Care | 6 −1 | 0.08% | −$76M | 3 / 4 | 1 / 2 |
| SNY | Sanofi SA | Health Care | 6 +1 | 0.06% | −$1.3B | 2 / 1 | 1 / 0 |
| IQV | Iqvia Hldgs Inc. | Health Care | 6 −3 | 0.05% | −$91M | 2 / 6 | 1 / 4 |
| NVST | Envista Holdings Corporation | Health Care | 6 +1 | 0.05% | −$80M | 2 / 3 | 1 / 0 |
| HSIC | Henry Schein, Inc. | Health Care | 6 +1 | 0.03% | −$500K | 2 / 2 | 1 / 0 |
| ALKS | Alkermes PLC | Health Care | 6 | 0.03% | −$9M | 2 / 1 | 1 / 1 |
| EW | Edwards Lifesciences Corp. | Health Care | 6 +2 | 0.03% | +$90M | 3 / 1 | 2 / 0 |
| GILD | Gilead Sciences, Inc. | Health Care | 6 +2 | 0.02% | −$281M | 3 / 1 | 2 / 0 |
| BNTX | Biontech Se | Health Care | 6 +1 | 0.02% | +$13M | 1 / 1 | 1 / 0 |
| RPRX | Royalty Pharma PLC | Health Care | 5 +1 | 0.15% | +$34M | 2 / 1 | 1 / 0 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 5 +1 | 0.15% | +$58M | 2 / 1 | 1 / 0 |
| ZTS | Zoetis Inc. | Health Care | 5 | 0.11% | +$118M | 3 / 2 | 1 / 1 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 5 | 0.10% | −$24M | 1 / 2 | 0 / 0 |
| VTRS | Viatris Inc. | Health Care | 5 +1 | 0.08% | −$494K | 2 / 1 | 1 / 0 |
| CNC | Centene Corp. Del | Health Care | 5 −1 | 0.05% | +$211M | 3 / 1 | 0 / 1 |
| BKD | Brookdale Sr Living Inc. | Health Care | 5 +2 | 0.05% | +$10M | 3 / 1 | 2 / 0 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 5 −1 | 0.04% | +$12M | 2 / 1 | 0 / 1 |
| ROIV | Roivant Sciences Ltd | Health Care | 5 −1 | 0.03% | +$320M | 2 / 2 | 1 / 2 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 5 +1 | 0.03% | +$87M | 3 / 1 | 2 / 1 |
| NUVB | Nuvation Bio Inc. | Health Care | 5 +1 | <0.01% | +$8M | 1 / 2 | 1 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 4 +1 | 0.17% | −$163M | 2 / 1 | 1 / 0 |
| MCK | Mckesson Corp. | Health Care | 4 −2 | 0.15% | +$173M | 1 / 5 | 1 / 3 |
| ALC | Alcon AG | Health Care | 4 +1 | 0.12% | +$170M | 3 / 1 | 1 / 0 |
| WGS | Genedx Holdings Corp. | Health Care | 4 | 0.07% | +$54M | 3 / 1 | 0 / 0 |
| MEDP | Medpace Holdings Inc. | Health Care | 4 −1 | 0.06% | +$71M | 2 / 2 | 0 / 1 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.05% | −$1M | 0 / 1 | 0 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 4 | 0.05% | −$162M | 2 / 2 | 1 / 1 |
| XRAY | Dentsply Sirona Inc. | Health Care | 4 +1 | 0.04% | +$25M | 2 / 1 | 1 / 0 |
| ALGN | Align Technology Inc. | Health Care | 4 | 0.04% | −$3M | 0 / 2 | 0 / 0 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 4 | 0.03% | +$398K | 2 / 1 | 0 / 0 |
| RGEN | Repligen Corp. | Health Care | 4 +2 | 0.03% | +$186M | 3 / 0 | 2 / 0 |
| STOK | Stoke Therapeutics Inc. | Health Care | 4 | 0.03% | +$1M | 2 / 0 | 0 / 0 |
| ANNX | Annexon Inc. | Health Care | 4 +1 | 0.03% | +$1M | 2 / 2 | 1 / 0 |
| NAMS | Newamsterdam Pharma Company | Health Care | 4 | 0.03% | +$10M | 2 / 1 | 1 / 1 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 4 +1 | 0.03% | +$9M | 1 / 3 | 1 / 0 |
| URGN | Urogen Pharma Ltd | Health Care | 4 | 0.03% | +$21M | 1 / 0 | 0 / 0 |
| FOLD | Amicus Therapeutic | Health Care | 4 +1 | 0.02% | −$48M | 2 / 1 | 1 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 4 +2 | 0.02% | +$21M | 3 / 1 | 2 / 0 |
| LH | Labcorp Holdings Inc. | Health Care | 4 | 0.02% | −$7M | 0 / 2 | 0 / 0 |
| MOH | Molina Healthcare Inc. | Health Care | 4 +2 | 0.02% | −$90M | 2 / 1 | 2 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 4 −1 | 0.02% | +$6M | 2 / 1 | 0 / 1 |
| DXCM | Dexcom Inc. | Health Care | 4 +1 | 0.02% | +$5M | 1 / 1 | 1 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 4 | 0.02% | −$10M | 2 / 1 | 1 / 1 |
| AXGN | Axogen Inc. | Health Care | 4 +1 | 0.01% | +$12M | 1 / 2 | 1 / 0 |
| CDNA | Caredx Inc. | Health Care | 4 | 0.01% | +$6M | 3 / 0 | 0 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 4 | 0.01% | −$4M | 0 / 1 | 0 / 0 |
| EHC | Encompass Health Corp. | Health Care | 4 | <0.01% | −$21M | 2 / 2 | 1 / 1 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 4 +1 | <0.01% | −$240M | 3 / 1 | 1 / 0 |
| BTI | British Amern Tob PLC | Health Care | 4 | <0.01% | +$17M | 2 / 0 | 0 / 0 |
| RDNT | Radnet Inc. | Health Care | 4 | <0.01% | −$5M | 1 / 1 | 0 / 0 |
| TERN | Terns Pharmaceuticals Inc. | Health Care | 4 +3 | <0.01% | +$2M | 3 / 1 | 3 / 0 |
| GH | Guardant Health Inc. | Health Care | 4 +1 | <0.01% | −$24M | 2 / 2 | 1 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 3 +2 | 0.31% | +$71M | 2 / 0 | 2 / 0 |
| SGRY | Surgery Partners Inc. | Health Care | 3 | 0.28% | −$13M | 1 / 1 | 0 / 0 |
| UTHR | United Therapeutics Corp. | Health Care | 3 +1 | 0.19% | −$1M | 2 / 1 | 1 / 0 |
| NVAX | Novavax Inc. | Health Care | 3 +1 | 0.17% | +$32M | 2 / 1 | 1 / 0 |
| OSCR | Oscar Health Inc. | Health Care | 3 −1 | 0.16% | −$6M | 0 / 3 | 0 / 1 |
| COO | Cooper Cos Inc. | Health Care | 3 −1 | 0.12% | −$17M | 0 / 2 | 0 / 1 |
| INSM | Insmed Inc. | Health Care | 3 −2 | 0.12% | −$72M | 0 / 5 | 0 / 2 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 3 | 0.11% | +$3M | 2 / 0 | 0 / 0 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 3 | 0.09% | +$7M | 1 / 0 | 0 / 0 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.07% | −$115M | 0 / 3 | 0 / 0 |
| TFX | Teleflex Incorporated | Health Care | 3 −1 | 0.07% | +$208M | 2 / 2 | 1 / 2 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 3 +1 | 0.05% | −$3M | 1 / 2 | 1 / 0 |
| MTD | Mettler Toledo International | Health Care | 3 −1 | 0.05% | −$98M | 0 / 2 | 0 / 1 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 3 | 0.04% | +$9M | 3 / 0 | 0 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 3 | 0.04% | −$27M | 0 / 2 | 0 / 0 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 3 | 0.03% | +$16M | 2 / 0 | 0 / 0 |
| CRSP | Crispr Therapeutics AG | Health Care | 3 | 0.03% | +$38M | 1 / 0 | 0 / 0 |
| BEAM | Beam Therapeutics Inc. | Health Care | 3 | 0.03% | −$6M | 0 / 0 | 0 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 3 +1 | 0.03% | −$7M | 2 / 2 | 2 / 1 |
| CMPS | Compass Pathways PLC | Health Care | 3 | 0.02% | +$15M | 2 / 0 | 0 / 0 |
| EMBC | Embecta Corporation | Health Care | 3 | 0.02% | +$16M | 3 / 1 | 1 / 1 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 3 | 0.02% | −$6M | 0 / 0 | 0 / 0 |
| VEEV | Veeva Systems Inc. Class A | Health Care | 3 −3 | 0.02% | −$570M | 2 / 4 | 0 / 3 |
| HOLX | Hologic Inc. | Health Care | 3 | 0.02% | +$131M | 2 / 1 | 1 / 1 |
| PCVX | Vaxcyte Inc. | Health Care | 3 +1 | 0.02% | +$121M | 2 / 0 | 1 / 0 |
| A | Agilent Technologies Inc. | Health Care | 3 −1 | 0.02% | −$47M | 0 / 3 | 0 / 1 |
| DNLI | Denali Therapeutics Inc. | Health Care | 3 | 0.02% | −$7M | 1 / 1 | 0 / 0 |
| BFLY | Butterfly Network Inc. | Health Care | 3 | 0.01% | −$4M | 0 / 2 | 0 / 0 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 3 +1 | <0.01% | −$7M | 1 / 1 | 1 / 0 |
| SRTA | Strata Critical Medical Inc. | Health Care | 3 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| ASND | Ascendis Pharma A/S | Health Care | 3 −1 | <0.01% | −$1M | 1 / 2 | 0 / 1 |
| IMVT | Immunovant Inc. | Health Care | 3 +1 | <0.01% | +$40M | 2 / 0 | 1 / 0 |
| KPTI | Karyopharm Therapeutics Inc. | Health Care | 3 −1 | <0.01% | −$3M | 1 / 2 | 0 / 1 |
| PODD | Insulet Corp. | Health Care | 3 +1 | <0.01% | +$3M | 3 / 0 | 1 / 0 |
| VCYT | Veracyte Inc. | Health Care | 3 | <0.01% | −$27M | 0 / 1 | 0 / 0 |
| Inmode | Inmode Ltd | Health Care | 3 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 3 | <0.01% | +$3M | 1 / 1 | 0 / 0 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 3 +1 | <0.01% | +$92K | 1 / 0 | 1 / 0 |
| SDGR | Schrodinger Inc. | Health Care | 3 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| AXSM | Axsome Therapeutics | Health Care | 3 +1 | <0.01% | +$354K | 1 / 0 | 1 / 0 |
| HIMS | Hims & Hers Health Inc. | Health Care | 3 +1 | <0.01% | −$71M | 1 / 2 | 1 / 0 |
| INSP | Inspire Med Sys Inc. | Health Care | 3 −1 | <0.01% | −$4M | 1 / 2 | 0 / 1 |
| PGNY | Progyny Inc. | Health Care | 3 −1 | <0.01% | −$5M | 1 / 2 | 0 / 1 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$92K | 0 / 1 | 0 / 0 |
| Compugen | Compugen Ltd | Health Care | 3 +1 | <0.01% | +$2M | 1 / 1 | 1 / 0 |
| CELC | Celcuity Inc. | Health Care | 3 | <0.01% | +$893K | 1 / 1 | 0 / 0 |
| GMED | Globus Med Inc. | Health Care | 3 +2 | <0.01% | +$2M | 2 / 0 | 2 / 0 |
| LQDA | Liquidia Corporation | Health Care | 2 −1 | 0.10% | +$3M | 1 / 1 | 0 / 1 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 2 | 0.10% | −$9M | 1 / 1 | 1 / 1 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 | 0.07% | +$7M | 1 / 1 | 0 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 2 +1 | 0.07% | +$744K | 1 / 0 | 1 / 0 |
| JBIO | Jade Biosciences Inc. | Health Care | 2 | 0.06% | $0 | 0 / 0 | 0 / 0 |
| CATX | Perspective Therapeutics Inc. | Health Care | 2 −1 | 0.06% | +$25M | 2 / 1 | 0 / 1 |
| IRON | Disc Medicine Inc. | Health Care | 2 | 0.05% | +$20M | 2 / 0 | 0 / 0 |
| SHC | Sotera Health Co. | Health Care | 2 | 0.04% | +$23M | 1 / 0 | 0 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 2 | 0.03% | +$3M | 1 / 0 | 0 / 0 |
| APGE | Apogee Therapeutics Inc. | Health Care | 2 +1 | 0.03% | +$1M | 1 / 0 | 1 / 0 |
| INDV | Indivior Pharmaceuticals Inc. | Health Care | 2 −1 | 0.03% | −$291M | 0 / 3 | 0 / 1 |
| OPCH | Option Care Health Inc. | Health Care | 2 | 0.03% | +$3M | 1 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 2 | 0.03% | +$4M | 1 / 0 | 0 / 0 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 2 | 0.03% | +$8M | 2 / 0 | 0 / 0 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | 0.03% | −$3M | 0 / 1 | 0 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | 0.02% | −$8K | 0 / 0 | 0 / 0 |
| PBH | Prestige Consmr Healthcare I | Health Care | 2 | 0.02% | +$10M | 0 / 0 | 0 / 0 |
| INCY | Incyte Corp. | Health Care | 2 −1 | 0.02% | −$123M | 0 / 3 | 0 / 1 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 2 | 0.02% | −$1M | 0 / 1 | 0 / 0 |
| NKTR | Nektar Therapeutics | Health Care | 2 +1 | 0.02% | +$7M | 2 / 0 | 1 / 0 |
| PGEN | Precigen Inc. | Health Care | 2 −1 | 0.02% | −$3M | 0 / 1 | 0 / 1 |
| MBX | Mbx Biosciences Inc. | Health Care | 2 | 0.02% | +$304K | 1 / 0 | 0 / 0 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 | 0.02% | +$18M | 1 / 0 | 0 / 0 |
| AKTS | Aktis Oncology Inc. IPO or spin-off | Health Care | 2 +2 | 0.01% | +$11M | 2 / 0 | 2 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 2 +1 | 0.01% | +$16M | 1 / 0 | 1 / 0 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 2 | 0.01% | −$14M | 1 / 1 | 0 / 0 |
| RMD | Resmed Inc. | Health Care | 2 | 0.01% | −$1M | 0 / 0 | 0 / 0 |
| CLDX | Celldex Therapeutics Inc. | Health Care | 2 +1 | 0.01% | +$9M | 1 / 0 | 1 / 0 |
| DVA | Davita Inc. | Health Care | 2 +1 | 0.01% | −$250M | 1 / 1 | 1 / 0 |
| CAI | Caris Life Sciences Inc. | Health Care | 2 | 0.01% | +$27M | 1 / 1 | 1 / 1 |
| ALMS | Alumis Inc. | Health Care | 2 +1 | 0.01% | +$573K | 1 / 0 | 1 / 0 |
| VIR | Vir Biotechnology Inc. IPO or spin-off | Health Care | 2 +2 | 0.01% | +$7M | 2 / 0 | 2 / 0 |
| LKFT | Galapagos NV | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ARDX | Ardelyx Inc. | Health Care | 2 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 2 | <0.01% | +$7M | 0 / 0 | 0 / 0 |
| CGON | Cg Oncology Inc. | Health Care | 2 −1 | <0.01% | −$76M | 1 / 2 | 0 / 1 |
| CAPR | Capricor Therapeutics Inc. | Health Care | 2 | <0.01% | +$105K | 0 / 0 | 0 / 0 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | −$57M | 1 / 1 | 1 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 2 | <0.01% | +$2M | 2 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 2 | <0.01% | −$18M | 2 / 1 | 1 / 1 |
| GRAL | Grail Inc. | Health Care | 2 −1 | <0.01% | +$46M | 1 / 1 | 0 / 1 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$114K | 0 / 0 | 0 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 2 | <0.01% | +$6M | 1 / 0 | 0 / 0 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | +$7M | 2 / 0 | 0 / 0 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | −$26K | 0 / 0 | 0 / 0 |
| EDIT | Editas Medicine Inc. | Health Care | 2 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 | <0.01% | +$16M | 1 / 0 | 0 / 0 |
| ADMA | Adma Biologics Inc. | Health Care | 2 −1 | <0.01% | −$95M | 1 / 2 | 0 / 1 |
| BLTE | Belite Bio Inc. Sponsored IPO or spin-off | Health Care | 2 +2 | <0.01% | +$17M | 2 / 0 | 2 / 0 |
| KRYS | Krystal Biotech | Health Care | 2 | <0.01% | −$246K | 0 / 1 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 2 −1 | <0.01% | −$3M | 0 / 1 | 0 / 1 |
| VSTM | Verastem | Health Care | 2 | <0.01% | −$9M | 2 / 1 | 1 / 1 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$10M | 0 / 2 | 0 / 0 |
| PROF | Profound Med Corp. | Health Care | 2 | <0.01% | −$82K | 0 / 1 | 0 / 0 |
| SION | Sionna Therapeutics Inc. | Health Care | 2 | <0.01% | −$180K | 0 / 1 | 0 / 0 |
| HALO | Halozyme Therapeutics | Health Care | 2 | <0.01% | −$12K | 0 / 1 | 0 / 0 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 2 −2 | <0.01% | −$20M | 0 / 2 | 0 / 2 |
| IRD | Opus Genetics Inc. | Health Care | 2 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| MANE | Veradermics Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$111M | 2 / 0 | 2 / 0 |
| MAZE | Maze Therapeutics Inc. | Health Care | 2 +2 | <0.01% | +$12M | 2 / 0 | 2 / 0 |
| BBNX | Beta Bionics Inc. | Health Care | 2 | <0.01% | −$7M | 0 / 1 | 0 / 0 |
| TMDX | Transmedics Group Inc. | Health Care | 2 | <0.01% | −$339K | 0 / 1 | 0 / 0 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| HQY | Healthequity Inc. | Health Care | 2 −2 | <0.01% | −$3M | 0 / 3 | 0 / 2 |
| BLLN | Billiontoone Inc. | Health Care | 2 | <0.01% | +$45M | 1 / 0 | 0 / 0 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 2 −1 | <0.01% | +$386K | 1 / 1 | 0 / 1 |
| TALK | Talkspace Inc. | Health Care | 2 +1 | <0.01% | +$6M | 1 / 1 | 1 / 0 |
| BBOT | Bridgebio Oncology Therapeut | Health Care | 2 +2 | <0.01% | +$846K | 2 / 0 | 2 / 0 |
| QURE | Uniqure NV | Health Care | 2 | <0.01% | +$586K | 1 / 0 | 0 / 0 |
| ARQT | Arcutis Biotherapeutics Inc. | Health Care | 2 | <0.01% | +$13M | 1 / 0 | 0 / 0 |
| MRVI | Maravai Lifesciences Hldgs I | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$7M | 0 / 1 | 0 / 0 |
| SRRK | Scholar Rock Hldg Corp. | Health Care | 2 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| COR | Cencora Inc. | Health Care | 2 −1 | <0.01% | −$3M | 0 / 1 | 0 / 1 |
| CON | Concentra Group Holdings Par | Health Care | 2 +1 | <0.01% | +$948K | 1 / 0 | 1 / 0 |
| LIVN | Livanova PLC | Health Care | 2 +1 | <0.01% | +$956K | 1 / 0 | 1 / 0 |
| NUVL | Nuvalent Inc. | Health Care | 2 | <0.01% | +$654K | 1 / 0 | 0 / 0 |
| ALVO | Alvotech | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| ABVX | Abivax SA | Health Care | 2 | <0.01% | −$45M | 0 / 2 | 0 / 0 |
| HROW | Harrow Inc. | Health Care | 1 | 0.10% | −$38M | 0 / 1 | 0 / 0 |
| BHC | Bausch Health Cos Inc. | Health Care | 1 −2 | 0.09% | −$9M | 0 / 2 | 0 / 2 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | 0.07% | −$539K | 0 / 1 | 0 / 0 |
| OGN | Organon & Co. | Health Care | 1 | 0.04% | +$11M | 1 / 0 | 0 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | 0.04% | $0 | 0 / 0 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 1 | 0.04% | −$3M | 0 / 1 | 0 / 0 |
| SLGL | Sol-Gel Technologies Ltd | Health Care | 1 | 0.04% | +$4M | 1 / 0 | 0 / 0 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | 0.03% | −$59M | 0 / 1 | 0 / 0 |
| ELVN | Enliven Therapeutics Inc. | Health Care | 1 | 0.03% | +$11M | 1 / 0 | 0 / 0 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 1 | 0.03% | −$1,000K | 0 / 1 | 0 / 0 |
| CBIO | Crescent Biopharma Inc. | Health Care | 1 | 0.02% | +$2M | 1 / 0 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | 0.02% | −$2M | 0 / 1 | 0 / 0 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | 0.02% | −$1M | 0 / 1 | 0 / 0 |
| ERFSF | Eurofins Scientific IPO or spin-off | Health Care | 1 +1 | 0.02% | +$224M | 1 / 0 | 1 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | 0.02% | +$39K | 0 / 0 | 0 / 0 |
| MGTX | Meiragtx Hldgs PLC | Health Care | 1 | 0.02% | +$15M | 1 / 0 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 1 | 0.02% | +$12M | 0 / 0 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| SNWV | Sanuwave Health Inc. | Health Care | 1 | 0.02% | $0 | 0 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | 0.02% | +$270K | 0 / 0 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 1 | 0.02% | −$202K | 0 / 0 | 0 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 1 | 0.02% | +$5M | 1 / 0 | 0 / 0 |
| PVLA | Palvella Therapeutics Inc. Ne | Health Care | 1 | 0.01% | +$7M | 1 / 0 | 0 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | 0.01% | −$1M | 0 / 1 | 0 / 0 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 1 | 0.01% | +$1M | 0 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 | 0.01% | +$51M | 1 / 0 | 0 / 0 |
| BHVN | Biohaven Ltd | Health Care | 1 | 0.01% | −$926K | 0 / 1 | 0 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| IPSC | Century Therapeutics Inc. | Health Care | 1 | <0.01% | −$812K | 0 / 1 | 0 / 0 |
| XOMA | Xoma Royalty Corporation | Health Care | 1 | <0.01% | +$232K | 0 / 0 | 0 / 0 |
| CMPX | Compass Therapeutics Inc. | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | +$112K | 0 / 0 | 0 / 0 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | −$83M | 0 / 1 | 0 / 0 |
| QTTB | Q32 Bio Inc. | Health Care | 1 | <0.01% | +$7M | 1 / 0 | 0 / 0 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$9M | 1 / 0 | 0 / 0 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | +$175K | 0 / 0 | 0 / 0 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$29K | 0 / 0 | 0 / 0 |
| RLMD | Relmada Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| MPLT | Maplight Therapeutics Inc. | Health Care | 1 | <0.01% | +$554K | 1 / 0 | 0 / 0 |
| TENX | Tenax Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| TYRA | Tyra Biosciences Inc. | Health Care | 1 | <0.01% | +$58M | 1 / 0 | 0 / 0 |
| PEN | Penumbra Inc. | Health Care | 1 | <0.01% | +$62M | 1 / 1 | 1 / 1 |
| MSLE | Satellos Bioscience Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| PRCT | Procept Biorobotics Corp. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$485K | 1 / 0 | 0 / 0 |
| STRO | Sutro Biopharma Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| DERM | Journey Med Corp. | Health Care | 1 | <0.01% | −$70K | 0 / 0 | 0 / 0 |
| VYGR | Voyager Therapeutics Inc. | Health Care | 1 | <0.01% | −$181K | 0 / 0 | 0 / 0 |
| RAPP | Rapport Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| TECX | Tectonic Therapeutic Inc. | Health Care | 1 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| LXEO | Lexeo Therapeutics Inc. | Health Care | 1 | <0.01% | +$208K | 1 / 0 | 0 / 0 |
| CABA | Cabaletta Bio Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| BDSX | Biodesix Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$3M | 1 / 0 | 1 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ALEC | Alector Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 1 −1 | <0.01% | −$739K | 0 / 1 | 0 / 1 |
| OLMA | Olema Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$14M | 1 / 1 | 1 / 1 |
| ZNTL | Zentalis Pharmaceuticals Inc. | Health Care | 1 | <0.01% | +$27K | 0 / 0 | 0 / 0 |
| CRVS | Corvus Pharmaceuticals Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| PSNL | Personalis Inc. | Health Care | 1 −1 | <0.01% | +$91K | 0 / 1 | 0 / 1 |
| BTSG | Brightspring Health Svcs Inc. | Health Care | 1 | <0.01% | +$68M | 1 / 0 | 0 / 0 |
| FBIO | Fortress Biotech Inc. | Health Care | 1 | <0.01% | −$134K | 0 / 0 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | +$11M | 1 / 0 | 0 / 0 |
| FULC | Fulcrum Therapeutics Inc. | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| AQST | Aquestive Therapeutics Inc. | Health Care | 1 | <0.01% | −$31K | 0 / 0 | 0 / 0 |
| KIDS | Orthopediatrics Corp. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$2M | 1 / 0 | 1 / 0 |
| Select Med | Select Med Hldgs Corp. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$30M | 1 / 0 | 1 / 0 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| CORT | Corcept Therapeutics Inc. | Health Care | 1 | <0.01% | +$372K | 1 / 0 | 0 / 0 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$11M | 0 / 1 | 0 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2025 Q4 and 2026 Q1: 136 this time. Not in 2026 Q1: Tom Bancroft - Makaira Partners.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.